Cargando…
ADAR1 Inhibits HBV DNA Replication via Regulating miR-122-5p in Palmitic Acid Treated HepG2.2.15 Cells
BACKGROUND AND AIMS: Changes in living standards and diet structure, non-alcoholic fatty liver disease (NAFLD) is prevalent globally, including in Asia, where chronic hepatitis B (CHB) is endemic. As such, cooccurrence of NAFLD with CHB is common in Asia. However, the pathogenesis underlying the ons...
Autores principales: | Yang, Hongli, Rui, Fajuan, Li, Rui, Yin, Shengxia, Xue, Qi, Hu, Xinyu, Xu, Yayun, Wu, Chao, Shi, Junping, Li, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793725/ https://www.ncbi.nlm.nih.gov/pubmed/36582505 http://dx.doi.org/10.2147/DMSO.S373385 |
Ejemplares similares
-
HBV Integration-mediated Cell Apoptosis in HepG2.2.15
por: Hu, Xiaoge, et al.
Publicado: (2019) -
MicroRNA-520a suppresses HBV replication in HepG2.2.15 cells by inactivating AKT
por: Sun, Wei, et al.
Publicado: (2018) -
Two fragments of HBV DNA integrated into chrX: 11009033 and its genetic regulation in HepG2.2.15
por: Ruan, Peng, et al.
Publicado: (2023) -
Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line
por: Yuan, Sen, et al.
Publicado: (2021) -
Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy
por: Zou, Jiang, et al.
Publicado: (2019)